These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24735615)

  • 1. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
    Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
    Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
    Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
    Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
    Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
    Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
    Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
    Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
    Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
    BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weifuchun suppresses the malignancy of gastric cancer cells by targeting KPNA2 through miR-26a-5p-mediated destabilization and the deactivation of the MAPK signaling pathway.
    Ma L; Hu X; Zhang W; Qi D; Chen L; Yin M
    J Ethnopharmacol; 2024 Nov; 334():118538. PubMed ID: 38992399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
    Ghosh MG; Thompson DA; Weigel RJ
    Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer.
    Liu M; Wang G; Gomez-Fernandez CR; Guo S
    PLoS One; 2012; 7(10):e46410. PubMed ID: 23056300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
    Wang L; Yi J; Lu LY; Zhang YY; Wang L; Hu GS; Liu YC; Ding JC; Shen HF; Zhao FQ; Huang HH; Liu W
    Theranostics; 2021; 11(4):1732-1752. PubMed ID: 33408778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ.
    Lü M; Ding K; Zhang G; Yin M; Yao G; Tian H; Lian J; Liu L; Liang M; Zhu T; Sun F
    Sci Rep; 2015 Mar; 5():8735. PubMed ID: 25736597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
    Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
    Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
    Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
    Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
    Maillot G; Lacroix-Triki M; Pierredon S; Gratadou L; Schmidt S; Bénès V; Roché H; Dalenc F; Auboeuf D; Millevoi S; Vagner S
    Cancer Res; 2009 Nov; 69(21):8332-40. PubMed ID: 19826037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
    Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
    Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
    Duan M; Hu F; Li D; Wu S; Peng N
    Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.